Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Reviva Pharmaceuticals Q3 EPS $(0.12)

Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.12) per share.

byBenzinga Newsdesk

November 15, 2021

1 minute read

Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.12) per share.

Bazelet Health Announces ACS Laboratory Analysis Shows 0% THC In Its Cannabis America Tri-Purpose Plant

By Vuk Zdinjak

Today, 11:49 PM

Bazelet Health Systems, Inc., a wholly owned subsidiary of Neon Bloom Inc.

NBCO

Media
News

Toyota Targets Starting Sales Of Small Electric Sedan In China By 2022-End

By Shivani Kumaresan

Today, 11:49 PM

Toyota Motor Corp (NYSE: TM) is expected to begin sales and production of a small electric sedan by the end of 2022.

Earnings

Looking Into Social Reality’s Return On Capital Employed

By Benzinga Insights

Today, 11:49 PM

According to Benzinga Pro data, during Q2, Social Reality (NASDAQ:SRAX) posted sales of $7.68 million. Earnings were up 25.04%, but Social Reality still reported an overall loss of $1.07 million.

SRAX

Socket Mobile Stock Jumps After Q2 Earnings Beat

By Anusuya Lahiri

Today, 11:49 PM

Socket Mobile Inc (NASDAQ:SCKT) reported second-quarter FY21 revenue growth of 119% year-on-year to $5.95 million, beating the consensus of $4.07 million.…

SCKT

Reviva Pharmaceuticals Q3 EPS $(0.12)

Related Posts

Bazelet Health Announces ACS Laboratory Analysis Shows 0% THC In Its Cannabis America Tri-Purpose Plant

Toyota Targets Starting Sales Of Small Electric Sedan In China By 2022-End

Looking Into Social Reality’s Return On Capital Employed

Socket Mobile Stock Jumps After Q2 Earnings Beat